<IPO>HENGRUI PHARMA IPO Said to Be Priced at Upper Limit of HKD44.05
China&#39;s innovative pharmaceutical company, HENGRUI PHARMA (01276.HK) will raise $9.89 bi...
China's innovative pharmaceutical company, HENGRUI PHARMA (01276.HK) will raise $9.89 billion in its IPO at a cap offer price of $44.05, IFR quoted sources as saying.
It was previously rumored that, due to strong demand for IPO subscription, HENGRUI PHARMA would close institutional investor subscriptions a day early at 5 PM on Monday (19th). It is reported that institutional investor demand has topped the entire offering size.
(HK stocks quote is delayed for at least 15 mins.)
Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.